Britain’s biggest private medical insurer is to start offering genetic testing and personalised prevention programmes, in a ...

Thousands of people with Westray or Whalsay ancestry could benefit from a new Scotland-wide genetic testing programme ...

Blended genome–exome sequencing reads key regions deeply and the rest of the genome shallowly, cutting costs and ancestry ...

In late July 2026, Myriad Genetics reported second-quarter 2026 results showing sales of US$190.7 million and a reduced net loss of US$43.2 million, while also lowering full-year 2026 revenue guidance ...

The BRCA1 and BRCA2 variants are associated with certain cancers.

Collaboration will extend access to enGenome’s interpretation platform across the global rare disease genomics network.

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 46.1% in the afternoon session after the company ...

Fibromyalgia is a disorder that can lead to symptoms like fatigue, widespread sensitivity, aches, and pains, as well as ...

The molecular diagnostics company's concurrent CLIA Waiver by Application, if granted, would allow testing in decentralised point-of-care settings.

The entire Australian population may be able to spit into a tube to test their risk of cancer or heart disease by 2030.

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) ...

Neurons that once encoded a person's memories are now helping researchers identify genetic targets that may one day help ...